
    
      The present trial will include subjects with diagnosed asthma in a provocation model which
      mimics assessments of asthma control. Mannitol challenge is an indirect asthma provocation
      test, which requires the presence of inflammatory cells, particularly mast cells, in the
      airways.

      The trial involved in total 5 subject visits and will last for a maximum of 30 days for each
      subject from Visit 2 (Randomisation) to Visit 5 (Follow up).

      Visit 2,3, and 4 will be treatment visits where Investigational Medicinal Product (IMP) is
      administrated 3 hours before the Mannitol challenge.
    
  